Introduction
thousands of years. The major pharmacological active ingredients of ginseng are ginsenosides which have many biological activities including antihyerlipidemic (Quan et al., 2012) , antidiabetic effect (Attele et al., 2002) , antioxidation (Zhang et al., 1996) , immunostimulation (Shin et al., 2002) , antistress (Wang and Lee, 2000) and anticancer (Lin et al., 2013) . Ginsenosides are divided into the protopanaxadiol, protopananatiol and oleanolic acid ginsenosides according to their structure (Xu et al., 2010a; Wang et al., 2012) . 20 (S)-Protopanaxadiol (PPD) is an active ginseng metabolite, which is the final form of protopanaxadiol saponins metabolized by human intestinal microflora (Figure 1 ) (Xie et al., 2009) . It was reported that 20 (S)-PPD showed anticancer effect in experimental animals and cultured cells though caspase-dependent and caspaseindependent pathway (Oh and Lee, 2004; Liu et al., 2007; Yu et al., 2007; Wang et al., 2008) . At present, 20 (S)-PPD has been developed into a Chinese medicine, named "Yijinsheng Capsule", to assist radiotherapy and chemotherapy, currently in clinical stage Ⅲ. Our previous study demonstrated that 20 (S)-PPD could induce apoptosis in A549 cell via the mitochondrial pathway and inhibited the phosphorylation of AKT (Zhang et al., 2013b) . However, the mechanism of cytotoxicity of 20 (S)-PPD has not been investigated. Therefore, in the present study, we investigated the cytotoxic mechanism of 20 (S)-PPD in human breast cancer MCF-7 cells.
Materials and Methods

Chemicals
20 (S)-Protopanaxadiol (PPD) was provided by Hainan Asian Pharmaceutical Co. Led., (China). The purity of 20 (S)-PPD used in experiments was >95% detected by HPLC. Antibodies against pro-caspase-3/-9, PARP, Bcl-2, Bax were purchased from Cell Signal Technology (Beverly, MA, USA). Antibody against β-actin was obtained from Tianjing Jingmai. Z-VAD-fmk was ordered from Santa Cruz Biotechology (Dallas, TX, USA). BCA protein assay reagent kit, DAPI staining kit, caspase activity assay kit and Rhodamine 123 were purchased from Beyotime Institue of Biotechnology (Jiangsu, China). Annexin V-FITC apoptosis detection kit was obtained from Tianjin Sungene Biotech Co. Ltd (Tianjin, China). MTT and all other reagents were purchased from SigmaAdrich Co. (St. Louis, MO, USA).
Cell culture and treatment
Human breast cancer MCF-7 cells were obtained from Shanghai Institute of Cell Biology, Chinese Academic of Science (Shanghai, China). MCF-7 cells were cultured in RPMI-1640 medium (Hyclone, Logan, UT, USA) supplemented with 10% heat-inactivated (56℃, 30min) fetal calf serum (GIBCO, Grand Island, NY, USA) under standard cultured conditions (37℃, 95% humidified air and 5% CO 2 ). 20 (S)-PPD dissolved in DMSO and was added to the culture media to the final concentrations.
MTT assay
Cell viability was measured by MTT assay as described previous (Xu et al., 2010b) . Briefly, the MCF-7 cells were seeded into 96-well plates, and treated with different concentration of 20 (S)-PPD (the final concentration of was 5, 10, 20, 40, 80μM) . After incubation for the 20h, 10 μl of MTT (Sigma, 5mg/ml in PBS) solution was added to each well and plates were then incubated another for 4h. Then 100 μl of dimethyl sulfoxide (DMSO) was added to each well, and the plates were shaken for 10 min. The absorbance was read at 570nm with a microplate reader (SpectraMax Plus384, Molecular Devices, USA). Percentage of survival was calculated as a fraction of the negative control. The half-maximal inhibitory concentration (IC 50 ) was calculated from the dose-response curve by original 6.0 software.
DAPI staining
The DAPI staining was performed as previously described (Matin et al., 2014) . Briefly, MCF-7 cells were seeded on coverslips with different concentrations of 20 (S)-PPD for 24h. The coverslips were washed twice with PBS, fixed in 4% paraformaldehyde, permeabilized with 0.1% Triton X-100 and stained with 2 μg/ml DAPI for 10min. Finally, the cells were observed under the fluorescence microscope (Nikon TE-2000U, Nikon Corporation, Tokyo, Japan).
Annexin V-FITC/PI assay
To quantify the apoptosis induced by 20 (S)-PPD in MCF-7 cells, Annexin V-FITC/PI staining was done by flow cytometry as previously described (Xu et al., 2010b) . Briefly, after 20 (S)-PPD treatment, MCF-7 cells were collected and washed twice in ice cold PBS and resuspended in 300 μl of binding buffer containing 1μg/ ml PI and 0.05μg/ml Annexin V-FITC. The samples were incubated for 15min at room temperature in dark and were analyzed by flow cytometry.
Mitochondrial membrane potential
Mitochondrial membrane potential was measured by using the mitochondrial membrane potential sensitive cationic dye Rhodamine 123 as previously described (Bomfim et al., 2013) . Briefly, MCF-7 cells treated with different concentration of 20 (S)-PPD for 24h and incubated with Rhodamine 123 at 37℃ for 30min. Flourescence intensities were analyzed by flow cytometric analysis.
Caspase activity assay
The activities of caspase-3, -9 were measured by colorimetric protease assay according to the manufacture's protocol. Briefly, cell lysates were prepared in cell lysis buffer for 15min on ice and centrifuged at 18, 000×g for 10min at 4℃. The supernatants were collected and total protein was quantified by Bradford method. Protein lysate was mixed with reaction buffer (Ac-DEVD-pNA for caspase-3, Ac-LEHD-pNA for caspase -9) and incubated at 37℃ for 2h in the dark. Developed color was measured at 405nm in microplate reader. Results are represented as the percentage of change of activity compared to the control.
Western blot analysis
Western blot was performed for detection of procaspase-9, -3 PARP, Bax and Bcl-2 proteins. After treatment with different concentration of 20 (S)-PPD, the MCF-7 cells were harvested and lysed in RIPA buffer for 30min on ice. The protein concentration was determined using the BCA protein assay kit. The cell extract (20μg) were loaded onto 12% polyacrylamide-SDS gel. After electrophoresis, the gel was blotted onto a PVDF DOI:http://dx.doi.org/10.7314/APJCP.2014.15.18.7919 20(S)-Protopanaxadiol Induces Human Breast Cancer MCF-7 Apoptosis through a Caspase-Mediated Pathway membrane, blocked with 5% (w/v) non-fat milk for 1h. The transferred membrane was incubated with appropriate primary antibodies at 4℃ overnight. Primary antibody binding was detected with secondary antibody conjugated to HRP, and visualized using ECL chemiluminescence.
Statistical analysis
The results are expressed as mean±SD for three independent experiments. Statistical differences were evaluated using Student's test or one-way analysis of variance (ANOVA). p<0.05 was considered to be significant. In an attempt to elucidate whether the loss in MCF-7 cell viability induced by 20 (S)-PPD was associated with apoptosis, the morphology changes were identified by DAPI staining. As shown in Figure 3A , DAPI staining showed relatively many apoptotic bodies containing nuclear fragments in MCF-7 cells treated with 20 (S)-PPD, but few were observed in control group. These data confirmed that 20 (S)-PPD induced apoptosis in MCF-7 cells. Furthermore, we also detected the apoptotic rate by Annexin V-FITC/PI staining. As shown in Figure 3B To further investigate the role of mitochondria in the apoptosis induced by 20 (S)-PPD, a flow cytometric analysis was performed. As shown in Figure 4A , treatment with 0, 5, 30 and 60μM 20 (S)-PPD for 24h, the MMP was decreased from 85.78% to 81.41%, 64.37% and 43.79%, respectively. With 20 (S)-PPD treatment, Bcl-2 protein level was down-regulated while Bax expression was upregulated ( Figure 4B ).
Results
MCF
As shown in Figure 5A , the caspase-3 and caspase-9 activities were markedly increased after treatment with different concentration of 20 (S)-PPD for 24h. Additionally, Figure 5B showed that z-VAD-fmk, a pan-caspase inhibitor, markedly attenuated the apoptosis induced by 20 (S)-PPD. As shown in Figure 5C , the cleavage of precursor of caspase-9 and capase-3 were noted with the presence of 20 (S)-PPD in a dose-dependent manner. PARP is a substrate for caspase-3. 20 (S)-PPD treatment caused cleavage of PARP, 116kDa to 89kDa fragment ( Figure 5C ). This corresponded with the activation of caspase-3.These suggested that 20 (S)-PPD induced apoptosis engages caspase-dependent signaling cascades. Taken together, our data suggest that 20 (S)-PPD induced apoptosis via caspase-mediated pathway in MCF-7 cells.
Discussion
Cancer has become an increasing public health issue for its high rates of morbidity and mortality. In the current study, the anticancer activity of 20 (S)-PPD was investigated. The experimental results showed that 20 (S)-PPD exhibited cytotoxicity to human breast cancer MCF-7 cells, with an IC 50 of 33.33μM ( Figure  2) . Apoptosis assay showed that apoptotic cells induced by 20 (S)-PPD exhibited cellular alterations, chromatin condensation by DAPI staining ( Figure 3A) . Annexin V-FITC/PI double-staining assay further confirmed the results of DAPI staining and the percentage of apoptosis increased in 20 (S)-PPD treatment ( Figure 3B ). All these results showed that 20 (S)-PPD increased anticancer activity through apoptosis.
Apoptosis is a cellular suicidal mechanism that regulates normal physiological processes and plays a crucial role in both the development and maintenance of tissue homeostasis (Hail et al., 2006) . The mitochondria play a pivotal role in apoptosis (Adams and Cory, 2007) . Here, the changes of mitochondrial membrane potential were analyzed by the Rhodamine 123 dye, the apoptosis is mediated by a rapid dissipation of mitochondrial membrane potential with 24h ( Figure 4A ). Bcl-2 family proteins are reported in regulation the function of mitochondria. Bcl-2 can stabilize mitochondria; in contrast, Bax increases the membrane permeability (Ly et al., 2003; Singh et al., 2013) . It is also reported that an increased ratio of Bax/Bcl-2 triggered the apoptosis. In this study, we observed that 20 (S)-PPD induced up-regulation of Bax and down-regulation of Bcl-2 ( Figure 4B ). It was supposed that 20 (S)-PPD might regulate the mitochondria function through disruption of a balance between the Bcl-2 and Bax protein. These results of the current study were consistent with the previously studies in other cancer cell types including human lung adenocarcinoma cells (Zhang et al., 2013b) , colon cancer cells (Zhang et al., 2013a) and prostate cancer cells (Chen et al., 2013) .
The caspase proteases are believed to play a critical role in mediating apoptosis. Two different caspase pathways (extrinsic and intrinsic pathways) are involved in mediating the response. Both extrinsic and intrinsic pathways lead to activation executioner caspase (caspase-3). Caspase-3 activated by caspase-8 (extrinsic pathway) or caspase-9 (intrinsic pathway) induces cell shrinkage, nuclear condensation and DNA fragmentation (Zhou et al., 2013) . Here, we showed that 20 (S)-PPD treatment activated caspase-9 and caspase-3 in a dosedependent manner ( Figure 5A ). Caspase-3 activation was dominant and reflected in the cleavage of PARP, a well-know substrate of caspase-3. During apoptosis, PARP was cleaved the precursor 116kDa to yield 85 kDa fragments (Allen et al., 1997) . As shown in Figure 5C , 20 (S)-PPD treatment caused the cleavage of PARP. This is corresponded with the activation of caspase-3 ( Figure  5A ). Moreover, the apoptosis induced by 20 (S)-PPD was markedly attenuated by z-VAD-fmk ( Figure 5B ), a pancaspase inhibitor. Taken together, our data suggest that 20 (S)-PPD induced apoptosis in MCF-7 cells through the activation of caspase cascades. However, further investigations were performed to highlight the apoptotic pathways involved in the apoptosis induced by 20 (S)-PPD in MCF-7 cells.
In conclusion, 20 (S)-PPD decreased mitochondrial membrane potential, enhanced the expression of Bax, activated the casapase-9 and caspase-3 and, subsequently, induced apoptosis in human breast cancer MCF-7 cells. These results showed the potential benefits of 20 (S)-PPD for clinical practice.
